tiprankstipranks
Aarti Pharmalabs Limited (IN:AARTIPHARM)
:AARTIPHARM
India Market
Want to see IN:AARTIPHARM full AI Analyst Report?

Aarti Pharmalabs Limited (AARTIPHARM) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

AARTIPHARM Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Aarti
Pharmalabs Limited
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AARTIPHARM Stock 12 Month Forecast

There Are No Analyst Ratings for IN:AARTIPHARM In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

AARTIPHARM Financial Forecast

AARTIPHARM Earnings Forecast

The previous quarter’s earnings for AARTIPHARM were ₹5.29.
The previous quarter’s earnings for AARTIPHARM were ₹5.29.

AARTIPHARM Sales Forecast

The previous quarter’s earnings for AARTIPHARM were ₹4.32B.
The previous quarter’s earnings for AARTIPHARM were ₹4.32B.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:AARTIPHARM
Unknown Analyst
ICICI Securities
Not Ranked
ICICI Securities
₹965
Buy
14.55%
Upside
Reiterated
02/11/26
Aarti Pharmalabs Limited (AARTIPHARM) Receives a Buy from ICICI Securities
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
ICICI Securities Analyst forecast on IN:AARTIPHARM
Unknown Analyst
ICICI Securities
Not Ranked
ICICI Securities
₹965
Buy
14.55%
Upside
Reiterated
02/11/26
Aarti Pharmalabs Limited (AARTIPHARM) Receives a Buy from ICICI Securities
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AARTIPHARM Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
0
1
1
1
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
1
1
1
0
In the current month, AARTIPHARM has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AARTIPHARM average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

AARTIPHARM Stock Forecast FAQ

What is IN:AARTIPHARM’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:AARTIPHARM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:AARTIPHARM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Aarti Pharmalabs Limited a Buy, Sell or Hold?
      Currently, no data Available
      What is Aarti Pharmalabs Limited’s share price target?
      Currently, no data Available
      What do analysts say about Aarti Pharmalabs Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Aarti Pharmalabs Limited?
      To buy shares of IN:AARTIPHARM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.